Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Transdermal bio-identical progesterone cream as hormonal treatment for osteoarthritis.

Wardhana, Surachmanto EE, Datau EA, Ongkowijaya J, Karema-Kaparang AM.

Acta Med Indones. 2013 Jul;45(3):224-32. Review.

2.

The role of cytokines in osteoarthritis pathophysiology.

Fernandes JC, Martel-Pelletier J, Pelletier JP.

Biorheology. 2002;39(1-2):237-46. Review.

PMID:
12082286
3.
4.

Obesity and inflammation--targets for OA therapy.

Iannone F, Lapadula G.

Curr Drug Targets. 2010 May;11(5):586-98. Review.

PMID:
20199391
6.

Cytokines as therapeutic targets for osteoarthritis.

Malemud CJ.

BioDrugs. 2004;18(1):23-35. Review.

PMID:
14733605
7.
8.

What makes osteoarthritis painful? The evidence for local and central pain processing.

Sofat N, Ejindu V, Kiely P.

Rheumatology (Oxford). 2011 Dec;50(12):2157-65. doi: 10.1093/rheumatology/ker283. Epub 2011 Sep 27. Review.

PMID:
21954151
9.

Osteoarthritis synovial fluid activates pro-inflammatory cytokines in primary human chondrocytes.

Hoff P, Buttgereit F, Burmester GR, Jakstadt M, Gaber T, Andreas K, Matziolis G, Perka C, Röhner E.

Int Orthop. 2013 Jan;37(1):145-51. doi: 10.1007/s00264-012-1724-1. Epub 2012 Dec 5.

10.

The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis.

Sutton S, Clutterbuck A, Harris P, Gent T, Freeman S, Foster N, Barrett-Jolley R, Mobasheri A.

Vet J. 2009 Jan;179(1):10-24. Epub 2007 Oct 29. Review.

PMID:
17911037
11.

Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.

Wang HJ, Yu CL, Kishi H, Motoki K, Mao ZB, Muraguchi A.

Chin Med J (Engl). 2006 Aug 20;119(16):1365-73.

PMID:
16934183
12.

Inflammatory mediators in osteoarthritis: A critical review of the state-of-the-art, current prospects, and future challenges.

Rahmati M, Mobasheri A, Mozafari M.

Bone. 2016 Apr;85:81-90. doi: 10.1016/j.bone.2016.01.019. Epub 2016 Jan 23. Review.

PMID:
26812612
13.

Synovial membrane inflammation and cytokine production in patients with early osteoarthritis.

Smith MD, Triantafillou S, Parker A, Youssef PP, Coleman M.

J Rheumatol. 1997 Feb;24(2):365-71.

PMID:
9034998
14.

Synovial immunopathology in haemochromatosis arthropathy.

Heiland GR, Aigner E, Dallos T, Sahinbegovic E, Krenn V, Thaler C, Weiss G, Distler JH, Datz C, Schett G, Zwerina J.

Ann Rheum Dis. 2010 Jun;69(6):1214-9. doi: 10.1136/ard.2009.120204. Epub 2009 Nov 23.

PMID:
19933745
15.

Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.

Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, Emery P, Poole AR, Veale DJ.

Arthritis Rheum. 2003 Nov;48(11):3085-95.

16.

High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts.

Wähämaa H, Schierbeck H, Hreggvidsdottir HS, Palmblad K, Aveberger AC, Andersson U, Harris HE.

Arthritis Res Ther. 2011 Aug 26;13(4):R136. doi: 10.1186/ar3450.

17.

Role of hormones in cartilage and joint metabolism: understanding an unhealthy metabolic phenotype in osteoarthritis.

Bay-Jensen AC, Slagboom E, Chen-An P, Alexandersen P, Qvist P, Christiansen C, Meulenbelt I, Karsdal MA.

Menopause. 2013 May;20(5):578-86. doi: 10.1097/GME.0b013e3182745993. Review.

PMID:
23615651
18.

Enhancement of SPARC (osteonectin) synthesis in arthritic cartilage. Increased levels in synovial fluids from patients with rheumatoid arthritis and regulation by growth factors and cytokines in chondrocyte cultures.

Nakamura S, Kamihagi K, Satakeda H, Katayama M, Pan H, Okamoto H, Noshiro M, Takahashi K, Yoshihara Y, Shimmei M, Okada Y, Kato Y.

Arthritis Rheum. 1996 Apr;39(4):539-51.

PMID:
8630101
19.

Piperine inhibits IL-β induced expression of inflammatory mediators in human osteoarthritis chondrocyte.

Ying X, Chen X, Cheng S, Shen Y, Peng L, Xu HZ.

Int Immunopharmacol. 2013 Oct;17(2):293-9. doi: 10.1016/j.intimp.2013.06.025. Epub 2013 Jul 6.

PMID:
23838114
20.

Supplemental Content

Support Center